BUSINESS
业务体系
Business Model
奥祺主营业务由三块构成：成熟制剂 License in、自研产品 License out，以及面向 CGT 早研项目的种子孵化服务。
Aoqi's business comprises three pillars: License-in of mature formulations, License-out of self-developed products, and incubation services for early-stage CGT projects.
01 · LICENSE IN
License-in
标的物：FDF
Subject: FDF
奥祺可以提供：
Aoqi provides:
- 中国市场的竞争机会评估
- 进口注册申报
- 市场推广和多渠道组合销售
- China market opportunity assessment
- Import registration filing
- Promotion and multi-channel sales
成功案例
Track record
雌三醇凝胶美普他酚注射液奥司他韦胶囊Estriol gelMeptazinol injectionOseltamivir capsules
02 · LICENSE OUT
License-out
标的物：FDF（奥祺研发）
Subject: FDF (developed by Aoqi)
产品特点：
Product profile:
- 近专利期重磅药物
- 完成 API 和制剂开发
- 部分产品已在半法规市场获批，或已在中国申报
- Near-cliff blockbuster drugs
- API and formulation development completed
- Some approved in semi-regulated markets or filed in China
推荐产品
Recommended products
吉泊达星片环硅酸锆钠散剂司美格鲁肽片利那洛肽胶囊诺西那生钠注射液恩利西肽片Gepotidacin tabletsSodium zirconium cyclosilicate powderSemaglutide tabletsLinaclotide capsulesNusinersen injectionEnlicitide tablets
03 · INCUBATION
种子孵化服务
Incubation Services
S & E · IP · BD · FA · PM
S & E · IP · BD · FA · PM
孵化方向：
Focus areas:
- 基因疗法
- 细胞疗法
- 核酸药物
- Gene therapy
- Cell therapy
- Nucleic acid therapeutics
服务内容
Services
S&EIPBDFAPMother supportS&EIPBDFAPMother support
